Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib plus BCG for carcinoma in situ, TaG3, and T1 bladder cancer
2006-004465-33Phase 2Completed
- Sponsor
- Eero Kaasinen
- Start
- Oct 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of celecoxib in bladder cancer and Bladder cancer in situ (CIS), sponsored by Eero Kaasinen. Started Oct 2006; status: completed.
02
Drugs
celecoxib
03
Conditions
bladder cancerBladder cancer in situ (CIS)
Beyond the preview
Go deeper on 2006-004465-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004465-33.